HEADER CELL CYCLE/TRANSFERASE 16-APR-08 2VRX TITLE STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 12-A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC KINASE DOMAIN, RESIDUES 77-361; COMPND 5 SYNONYM: AURORA-B-A, AURORA/IPL1-RELATED KINASE 2-A, COMPND 6 AIRK2-A, PROTEIN KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: INNER CENTROMERE PROTEIN A; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: RESIDUES 798-840; COMPND 12 SYNONYM: MITOTIC PHOSPHOPROTEIN 130, XL-INCENP SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 3 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 4 ORGANISM_TAXID: 8355; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 7 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 8 ORGANISM_TAXID: 8355 KEYWDS SERINE/THREONINE-PROTEIN KINASE, KINASE, NUCLEUS, MITOSIS, KEYWDS 2 MAGNESIUM, CELL CYCLE/TRANSFERASE, CENTROMERE, KEYWDS 3 MICROTUBULE, ATP-BINDING, TRANSFERASE, ANTI-CANCER DRUG KEYWDS 4 TARGET, PHOSPHOPROTEIN, PROTEIN KINASE, KEYWDS 5 NUCLEOTIDE-BINDING, COILED COIL, CELL DIVISION, KEYWDS 6 METAL-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR F.GIRDLER,F.SESSA,S.PATERCOLI,F.VILLA,E.RIDGWAY,A.MUSACCHIO, AUTHOR 2 S.S.TAYLOR REVDAT 2 24-FEB-09 2VRX 1 VERSN REVDAT 1 01-JUL-08 2VRX 0 JRNL AUTH F.GIRDLER,F.SESSA,S.PATERCOLI,F.VILLA,A.MUSACCHIO, JRNL AUTH 2 S.S.TAYLOR JRNL TITL MOLECULAR BASIS OF DRUG RESISTANCE IN AURORA JRNL TITL 2 KINASES. JRNL REF CHEM.BIOL. V. 15 552 2008 JRNL REFN ISSN 1074-5521 JRNL PMID 18559266 JRNL DOI 10.1016/J.CHEMBIOL.2008.04.013 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 115.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 52024 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2776 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3554 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE SET COUNT : 181 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5219 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 594 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.45000 REMARK 3 B22 (A**2) : 1.79000 REMARK 3 B33 (A**2) : -1.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.43000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.166 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.159 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.101 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.294 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5469 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 5469 ; 0.008 ; 0.022 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7384 ; 1.160 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7384 ; 1.160 ; 1.990 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 632 ; 5.238 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 265 ;34.897 ;22.717 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 982 ;14.775 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 50 ;16.684 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 753 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4187 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 4187 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2714 ; 0.196 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2714 ; 0.196 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3686 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 547 ; 0.128 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 140 ; 0.168 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 57 ; 0.135 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3261 ; 0.639 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5138 ; 1.072 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2528 ; 1.548 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2246 ; 2.541 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2VRX COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-APR-08. REMARK 100 THE PDBE ID CODE IS EBI-35953. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9340 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59143 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.85 REMARK 200 RESOLUTION RANGE LOW (A) : 30.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 2.1 REMARK 200 R MERGE (I) : 0.04 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.19 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2 REMARK 200 R MERGE FOR SHELL (I) : 0.33 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.68 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.50200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 77 REMARK 465 THR A 78 REMARK 465 ALA A 79 REMARK 465 LEU A 80 REMARK 465 ALA A 81 REMARK 465 GLU A 82 REMARK 465 MET A 83 REMARK 465 PRO A 84 REMARK 465 LYS A 85 REMARK 465 ARG A 86 REMARK 465 GLN A 356 REMARK 465 SER A 357 REMARK 465 THR A 358 REMARK 465 GLN A 359 REMARK 465 SER A 360 REMARK 465 LYS A 361 REMARK 465 LYS B 101 REMARK 465 GLY B 102 REMARK 465 LYS B 103 REMARK 465 PHE B 104 REMARK 465 GLN B 356 REMARK 465 SER B 357 REMARK 465 THR B 358 REMARK 465 GLN B 359 REMARK 465 SER B 360 REMARK 465 LYS B 361 REMARK 465 LYS C 839 REMARK 465 SER C 840 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN C 838 CA C O CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 112 - O HOH A 2024 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 158 -176.30 -178.10 REMARK 500 ASP A 162 -159.24 -126.38 REMARK 500 ASP A 216 44.38 -151.31 REMARK 500 SER A 243 -70.20 -120.75 REMARK 500 ARG A 348 50.11 -119.95 REMARK 500 VAL B 134 -32.63 106.72 REMARK 500 ASN B 158 -175.75 -172.42 REMARK 500 ASP B 162 -167.58 -121.23 REMARK 500 ASP B 216 43.53 -147.85 REMARK 500 ASN D 838 -167.76 -112.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 447 A1356 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 447 B1356 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BFX RELATED DB: PDB REMARK 900 MECHANISM OF AURORA-B ACTIVATION BY INCENP REMARK 900 AND INHIBITION BY HESPERADIN. REMARK 900 RELATED ID: 2VGO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA B KINASE IN REMARK 900 COMPLEX WITH REVERSINE INHIBITOR REMARK 900 RELATED ID: 2VGP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA B KINASE IN REMARK 900 COMPLEX WITH A AMINOTHIAZOLE INHIBITOR REMARK 900 RELATED ID: 2BFY RELATED DB: PDB REMARK 900 COMPLEX OF AURORA-B WITH INCENP AND REMARK 900 HESPERIDIN. DBREF 2VRX A 77 361 UNP Q6DE08 AUKBA_XENLA 77 361 DBREF 2VRX B 77 361 UNP Q6DE08 AUKBA_XENLA 77 361 DBREF 2VRX C 798 840 UNP O13024 INCEA_XENLA 798 840 DBREF 2VRX D 798 840 UNP O13024 INCEA_XENLA 798 840 SEQRES 1 A 285 ASN THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR SEQRES 2 A 285 ILE ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY SEQRES 3 A 285 LYS PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN SEQRES 4 A 285 LYS PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN SEQRES 5 A 285 LEU GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU SEQRES 6 A 285 ILE GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU SEQRES 7 A 285 ARG MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR SEQRES 8 A 285 LEU MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS SEQRES 9 A 285 GLU LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER SEQRES 10 A 285 ALA THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR SEQRES 11 A 285 CYS HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO SEQRES 12 A 285 GLU ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE SEQRES 13 A 285 ALA ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG SEQRES 14 A 285 ARG ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO SEQRES 15 A 285 GLU MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP SEQRES 16 A 285 LEU TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL SEQRES 17 A 285 GLY MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR SEQRES 18 A 285 HIS ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO SEQRES 19 A 285 PHE LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU SEQRES 20 A 285 LEU ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY SEQRES 21 A 285 VAL MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG SEQRES 22 A 285 VAL LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 B 285 ASN THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR SEQRES 2 B 285 ILE ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY SEQRES 3 B 285 LYS PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN SEQRES 4 B 285 LYS PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN SEQRES 5 B 285 LEU GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU SEQRES 6 B 285 ILE GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU SEQRES 7 B 285 ARG MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR SEQRES 8 B 285 LEU MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS SEQRES 9 B 285 GLU LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER SEQRES 10 B 285 ALA THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR SEQRES 11 B 285 CYS HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO SEQRES 12 B 285 GLU ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE SEQRES 13 B 285 ALA ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG SEQRES 14 B 285 ARG ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO SEQRES 15 B 285 GLU MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP SEQRES 16 B 285 LEU TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL SEQRES 17 B 285 GLY MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR SEQRES 18 B 285 HIS ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO SEQRES 19 B 285 PHE LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU SEQRES 20 B 285 LEU ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY SEQRES 21 B 285 VAL MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG SEQRES 22 B 285 VAL LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 C 43 ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN ALA SEQRES 2 C 43 ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP ARG SEQRES 3 C 43 MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU LEU SEQRES 4 C 43 PHE ASN LYS SER SEQRES 1 D 43 ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN ALA SEQRES 2 D 43 ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP ARG SEQRES 3 D 43 MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU LEU SEQRES 4 D 43 PHE ASN LYS SER MODRES 2VRX TPO A 248 THR MODIFIED THREONINE MODRES 2VRX TPO B 248 THR MODIFIED THREONINE HET TPO A 248 11 HET TPO B 248 11 HET 447 A1356 38 HET 447 B1356 38 HETNAM 447 N-(4-{[6-METHOXY-7-(3-MORPHOLIN-4-YLPROPOXY) HETNAM 2 447 QUINAZOLIN-4-YL]AMINO}PHENYL)BENZAMIDE HETNAM TPO PHOSPHOTHREONINE FORMUL 5 447 2(C29 H31 N5 O4) FORMUL 6 TPO 2(C4 H10 N O6 P) FORMUL 7 HOH *594(H2 O1) HELIX 1 1 THR A 89 ASP A 91 5 3 HELIX 2 2 LYS A 126 GLY A 133 1 8 HELIX 3 3 VAL A 134 HIS A 147 1 14 HELIX 4 4 LEU A 178 GLY A 186 1 9 HELIX 5 5 ASP A 189 GLU A 209 1 21 HELIX 6 6 LYS A 218 GLU A 220 5 3 HELIX 7 7 THR A 252 LEU A 256 5 5 HELIX 8 8 PRO A 257 GLU A 262 1 6 HELIX 9 9 LYS A 269 GLY A 285 1 17 HELIX 10 10 SER A 293 ASN A 303 1 11 HELIX 11 11 SER A 313 LEU A 324 1 12 HELIX 12 12 HIS A 327 ARG A 331 5 5 HELIX 13 13 PRO A 333 GLU A 339 1 7 HELIX 14 14 HIS A 340 SER A 347 1 8 HELIX 15 15 THR B 89 ASP B 91 5 3 HELIX 16 16 LYS B 126 GLU B 130 1 5 HELIX 17 17 VAL B 134 SER B 146 1 13 HELIX 18 18 LEU B 178 GLY B 186 1 9 HELIX 19 19 ASP B 189 ARG B 210 1 22 HELIX 20 20 LYS B 218 GLU B 220 5 3 HELIX 21 21 THR B 252 LEU B 256 5 5 HELIX 22 22 PRO B 257 GLU B 262 1 6 HELIX 23 23 LYS B 269 GLY B 285 1 17 HELIX 24 24 SER B 293 ASN B 303 1 11 HELIX 25 25 SER B 313 LEU B 324 1 12 HELIX 26 26 HIS B 327 ARG B 331 5 5 HELIX 27 27 PRO B 333 HIS B 340 1 8 HELIX 28 28 HIS B 340 SER B 347 1 8 HELIX 29 29 PRO C 799 ALA C 802 5 4 HELIX 30 30 SER C 803 LYS C 817 1 15 HELIX 31 31 ASP C 820 TYR C 825 1 6 HELIX 32 32 LYS C 832 PHE C 837 1 6 HELIX 33 33 PRO D 799 ALA D 802 5 4 HELIX 34 34 SER D 803 LYS D 817 1 15 HELIX 35 35 ASP D 820 TYR D 825 1 6 HELIX 36 36 LYS D 832 LEU D 836 5 5 SHEET 1 AA 5 PHE A 93 GLY A 100 0 SHEET 2 AA 5 VAL A 107 GLU A 112 -1 O VAL A 107 N LEU A 99 SHEET 3 AA 5 PHE A 117 PHE A 125 -1 O PHE A 117 N GLU A 112 SHEET 4 AA 5 ARG A 165 LEU A 170 -1 O ILE A 166 N LEU A 124 SHEET 5 AA 5 MET A 156 HIS A 161 -1 N TYR A 157 O MET A 169 SHEET 1 AB 3 GLY A 176 GLU A 177 0 SHEET 2 AB 3 LEU A 222 MET A 224 -1 N MET A 224 O GLY A 176 SHEET 3 AB 3 LEU A 230 ILE A 232 -1 O LYS A 231 N LEU A 223 SHEET 1 AC 2 VAL A 212 ILE A 213 0 SHEET 2 AC 2 VAL A 239 HIS A 240 -1 O VAL A 239 N ILE A 213 SHEET 1 BA 5 PHE B 93 PRO B 98 0 SHEET 2 BA 5 ASN B 106 GLU B 112 -1 O LEU B 109 N GLY B 96 SHEET 3 BA 5 PHE B 117 PHE B 125 -1 O PHE B 117 N GLU B 112 SHEET 4 BA 5 ARG B 165 LEU B 170 -1 O ILE B 166 N LEU B 124 SHEET 5 BA 5 MET B 156 HIS B 161 -1 N TYR B 157 O MET B 169 SHEET 1 BB 3 GLY B 176 GLU B 177 0 SHEET 2 BB 3 LEU B 222 MET B 224 -1 N MET B 224 O GLY B 176 SHEET 3 BB 3 LEU B 230 ILE B 232 -1 O LYS B 231 N LEU B 223 SHEET 1 BC 2 VAL B 212 ILE B 213 0 SHEET 2 BC 2 VAL B 239 HIS B 240 -1 O VAL B 239 N ILE B 213 LINK C ARG A 247 N TPO A 248 1555 1555 1.33 LINK C TPO A 248 N MET A 249 1555 1555 1.33 LINK C ARG B 247 N TPO B 248 1555 1555 1.33 LINK C TPO B 248 N MET B 249 1555 1555 1.33 CISPEP 1 LEU B 99 GLY B 100 0 0.91 CISPEP 2 GLU B 132 GLY B 133 0 -4.43 CISPEP 3 GLY B 133 VAL B 134 0 12.53 SITE 1 AC1 18 LEU A 99 ALA A 120 LYS A 122 LEU A 138 SITE 2 AC1 18 GLU A 141 GLN A 145 LEU A 154 MET A 156 SITE 3 AC1 18 LEU A 168 LEU A 170 GLU A 171 PHE A 172 SITE 4 AC1 18 ALA A 173 PRO A 174 ARG A 175 GLY A 176 SITE 5 AC1 18 LEU A 223 HOH A2151 SITE 1 AC2 17 VAL B 107 LYS B 122 GLU B 141 GLN B 145 SITE 2 AC2 17 LEU B 154 MET B 156 LEU B 170 GLU B 171 SITE 3 AC2 17 PHE B 172 ALA B 173 PRO B 174 GLY B 176 SITE 4 AC2 17 GLU B 177 LEU B 223 ALA B 233 ASP B 234 SITE 5 AC2 17 PHE B 235 CRYST1 45.735 67.004 116.583 90.00 96.93 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021865 0.000000 0.002658 0.00000 SCALE2 0.000000 0.014924 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008641 0.00000